The results of the conducted experiments populated a database that contained 30 body-fluid-specific protein biomarkers with candidates linked to each target body fluid. These include biomarker candidates to identify semen, saliva, urine, peripheral blood, menstrual blood, and vaginal fluid. The researcher advises, however, that although these results are encouraging, the discovery process was performed on the sample from only five individuals per bodily fluid; thus, these proteins can be considered only candidate biomarkers. This is because of the possibility that some candidate biomarkers might be secreted into non-target fluids, particularly with the less-documented proteins associated with vaginal fluid. Consequently, a larger scale study must be completed in order to provide a more rigorous confirmation of these candidates as being body-fluid-specific. The study identified just over 1,000 proteins by using 3 approaches. The biomarker-identification phase used multidimensional protein separation technologies, bioinformatics tool, and tandem mass spectrometry in developing a database of fluid-specific candidate markers for each targeted body fluid. The biomarker-verification phase used the most promising candidates from the biomarker-identification phase in developing a targeted multiplex assay on a Quadruple Time-of-Flight mass spectrometer in verifying the specificity of these candidate biomarkers with single-source laboratory samples, as well as single- and mixed-source casework-type samples. The prototype-validation phase developed and tested a case working laboratory prototype assay on a triple quadrupole mass spectrometer, using single- and mixed-source casework-type samples. 42 figures, 20 tables, 215 references, and appended supplementary data
Downloads
Similar Publications
- Development and Validation of a Method for Analysis of 25 Cannabinoids in Oral Fluid and Exhaled Breath Condensate
- In Vitro Structure-activity Relationships and Forensic Case Series of Emerging 2-benzylbenzimidazole 'Nitazene' Opioids
- Superhydrophobic Surface Modification of Polymer Microneedles Enables Fabrication of Multimodal Surface-Enhanced Raman Spectroscopy and Mass Spectrometry Substrates for Synthetic Drug Detection in Blood Plasma